Md. Rezwan Ahmed Mahedi

Mr. Md. Rezwan Ahmed Mahedi

Department of Pharmacy, Comilla University, Comilla, Chittagong, Bangladesh
+2
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Frontiers of Agricultural Science and Engineering
Verified
Journal Article
Closed access
DDDipta Dey
Dipta Dey
TETanzila Ismail Ema
Tanzila Ismail Ema
Partha BiswasPartha Biswas
Partha Biswas
SASharmin Aktar
Sharmin Aktar
SIShoeba Islam
Shoeba Islam
NBNasir Uddin Badal
Nasir Uddin Badal

12 October 2024 in Journal of Current Health Sciences
Verified
Journal Article
Open access
PDF file
Md. Rezwan Ahmed MahediMd. Rezwan Ahmed Mahedi
Md. Rezwan Ahmed Mahedi
HIHrishik Iqbal
Hrishik Iqbal
RARaiyan Azmee
Raiyan Azmee
MAMarzan Azmee
Marzan Azmee
FJFatiha Jakir
Fatiha Jakir
SASadia Afrin
Sadia Afrin
Artificial intelligence (AI) has rapidly transformed numerous industries, including medicine, with radiography standing to benefit significantly from its capabilities. AI enhances diagnostic accuracy, reduces errors, and improves patient care by leveraging large datasets from digital radiographs commonly used in medical and dental practices. Despite these advantages, the impact of AI on image acquisition and radiographer workflows remains underexplored in radiography literature. This review aims to evaluate the effects of AI on radiographic practices, address regulatory challenges, and explore its integration into educational frameworks for radiologists and radiographers. It highlights AI's role in automating tasks, enhancing diagnostic precision, and improving clinical decision-making. A systematic literature search was conducted using PubMed and Google Scholar up to December 2024, with terms including "artificial intelligence," "machine learning," "deep learning," "radiography," and "diagnostic imaging." Seventy-seven peer-reviewed articles and conference papers focusing on AI applications in digital dental radiography were analyzed to extract data on AI methodologies and their potential applications. The findings reveal that AI-powered solutions enhance efficiency in complex imaging tasks, such as lesion identification and triage in mammography, and real-time assessments in cross-sectional imaging, reducing the need for re-scans and increasing patient throughput. However, widespread adoption faces obstacles related to ethical and legal concerns, including data privacy, algorithmic bias, and the need for transparency. While AI demonstrates significant potential to automate workflows, improve diagnostic accuracy, and optimize patient care in radiography, challenges related to human oversight, professional adaptation, and regulatory compliance must be addressed. Further research is needed to fully understand AI’s impact on radiography and to maximize its clinical utility.

27 January 2025 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
PVPatrik Viktor
Patrik Viktor
LKLakhvinder Kaur
Lakhvinder Kaur
JHJai Shanker Pillai Hp
Jai Shanker Pillai Hp
OKOthman Mahjoob Khalaf
Othman Mahjoob Khalaf
MMMustafa Mudhafar
Mustafa Mudhafar
SSShahrin Risa Sejuti
Shahrin Risa Sejuti
The study of poisons and their effects includes detection, measurement, toxicity, fatal dose, and therapy. Medical and legal issues related to substance-induced injury are the focus of forensic toxicology. This study discusses poisonings, their consequences, and forensic investigations. Children are especially susceptible to poisoning from suicide attempts, murders, accidents, and unintended exposures. For profit or revenge, homicidal poisoning occurs. The paper describes toxic symptoms and diagnosing difficulties. Toxin-related gastrointestinal, ophthalmic, and cutaneous disorders, symptoms, and vital signs are included in tables. Skin examination is important for determining poisoning pathways because of cutaneous evidence. Visual impairments, ocular indicators, and poisoning symptoms are given to help identify dangerous chemicals. Poison control centres handle poisoning episodes, provide toxicological information, treatment guidance, public health surveillance, professional consultation, toxicovigilance, emergency response, and quality improvement. The report stresses the need of international collaboration in poison control centre establishment and maintenance. Healthcare professionals and the public need poison information sources, such as databases and apps, to manage poisoning incidents. A complete list of materials is provided. The study concludes by assessing poison exposure and poisoning circumstances, noting the many ways poisons may hurt or kill. The sensitivity of youngsters to even little amounts of narcotics is stressed. The research concludes that poisoning diagnosis is complicated due to the many symptoms and possible misdiagnoses. It emphasises evidence-based knowledge and poison control centres and information sources in managing and preventing poisonings.

22 April 2024 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
NNNujhat Nabilah
Nujhat Nabilah
DGDarío Salguero García
Darío Salguero García
SKSuresh Babu Kondaveeti
Suresh Babu Kondaveeti
HBH.S. Batra
H.S. Batra
PVPatrik Viktor
Patrik Viktor
Md. Rezwan Ahmed MahediMd. Rezwan Ahmed Mahedi
Md. Rezwan Ahmed Mahedi
The genesis of chronic skin illnesses is intricately intertwined with genetics, the environment, psychological and the immune system. However, recent studies have shown that mental health issues can exacerbate and control the severity of chronic skin disorders. Focusing on illnesses including psoriasis, atopic dermatitis, and urticaria, this article seeks to evaluate and discuss the current literature on the interplay of psychological aspects in chronic skin diseases. Here, we investigate the two-way connection between emotional discomfort (such as stress, worry, or depression) and the physiology of various skin conditions. Furthermore, we address possible mechanisms underlying the link between mental health and skin diseases, which will help the physicians to select the medicines and treatment approach.

7 March 2025 in Future Health
Verified
Journal Article
Open access
Md. Rezwan Ahmed MahediMd. Rezwan Ahmed Mahedi
Md. Rezwan Ahmed Mahedi
PRPujita Roy
Pujita Roy
ARAsma Akhter Radia
Asma Akhter Radia
SASadia Afrin
Sadia Afrin
FAFaisal Ahmed
Faisal Ahmed
NSNikolaos Syrmos
Nikolaos Syrmos
Public health in Bangladesh, especially in the last several years, has been greatly affected by dengue fever, caused by a virus spread by mosquitoes. The illness, which was first recorded in Dhaka in 1964, under the name “Dhaka Fever”, has continued to rise in both incidence and fatality rates despite the attempts to control it. With 96,228 cases and 531 fatalities recorded in 2024, Bangladesh is among the top nations for dengue mortality. Environmental changes, unplanned urbanization, and the adaptive behavior of mosquito species Aedes aegypti and Aedes albopictus are the causes of this dramatic increase. Due to increased temperatures and prolonged humidity caused by climate change, the breeding season is now longer than in the typical monsoon months, resulting in outbreaks that happen all year round. Expanded dengue syndrome and other new infection patterns and symptoms make diagnosis and treatment more challenging. The illness is more common in men of working age, yet it kills more women than men. There has been an uptick in cases and deaths in areas outside big cities as well, including Chittagong and Barisal. Identifying worrisome hotspots, controlling mosquito populations, and raising public awareness about unusual dengue symptoms are all necessary to combat this growing epidemic. This research highlights the critical need for implementing comprehensive plans to fight dengue and lessen its social and economic effects in Bangladesh.

27 December 2024 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
SASadia Afrin
Sadia Afrin
JHJai Shanker Pillai Hp
Jai Shanker Pillai Hp
CSChallaraj Emmanuel E S
Challaraj Emmanuel E S
PVPatrik Viktor
Patrik Viktor
AHAl Hafiz
Al Hafiz
MEMohammad Mahfuz Enam Elahi
Mohammad Mahfuz Enam Elahi
Drug development is both a task and a promise for fighting illnesses and improving health. Innovative treatments for cancer, infectious diseases, chronic illnesses, and uncommon genetic abnormalities have long been difficult and resource-intensive to develop. In the 21st century, bioinformatics has become a pioneering and essential technique for drug development. Bioinformatics uses computational algorithms, statistical analysis, and data-driven insights to understand life's core biological processes. Bioinformatics helps drug discovery researchers understand illness biological mechanisms, identify therapeutic targets, screen candidate molecules, and improve drug development pipelines. Drug development has been defined by fortuitous discoveries and tedious laboratory work, requiring years or decades to get a possible therapeutic agent to the patient bedside. Bioinformatics has transformed drug development in biomedicine today. This comprehensive study examines how bioinformatics has changed medication development. We want to study and analyse bioinformatics' many uses. We discover the complex network of genomes, proteomics, structural biology, and computational modelling that underscores bioinformatics' vital significance as we investigate this dynamic subject. This review illuminates the difficult balance between biological knowledge and computational capabilities to produce innovative treatments. The systematic review uses a thorough literature search, study selection criteria, and data extraction. Genomic target identification, virtual screening, pharmacophore modelling, pathway analysis, and toxicity prediction are among the bioinformatics applications in drug development we find and classify. These examples demonstrate bioinformatics' ability to accelerate medication development. The systematic review covers bioinformatics' drug discovery applications and shows how this diverse discipline is changing pharmaceutical research. It shows how to improve medication development, reduce side effects, and achieve precision medicine. The combination of bioinformatics and drug development offers optimism for easing human suffering, extending lifespans, and fighting a broad range of illnesses.